Hyperbaric Oxygen Therapy for Persistent Post Stroke Depression
ConditionPost Stroke Depression
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-85
SponsorAssaf-Harofeh Medical Center
About this trial
The study evaluates the effect of HBOT on depression in patients suffering from persistent symptoms of post stroke depression (PSD) in an double blind sham control study.
Eligibility criteria
Qualifiers
Age between 50 -85
Suffered an ischemic stroke 6 months to 7 years prior to their inclusion
Treated or being treated by antidepressants for at least 3 months
Diagnosis of PSD based on HDRS-17 score of 17 and above.
Disqualifiers
Inability to attend scheduled clinic visits and/or comply with the study protocol
Diagnosis of a psychiatric disorder prior to the recent stroke including: major depression, schizophrenia or bipolar disease.
Diagnosis of aphasia or major cognitive decline
History of Deep brain stimulation (DBS)
Trial design
Treatments tested in this trial
- hyperbaric oxygen therapy
Treatment groups
142 Participants
are divided into 2 treatment groupsLocations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
The Sagol Center for Hyperbaric Medicine and Research Shamir Medical Center (Assaf Harofeh)Recruiting70300, Zrifin
Israel
IsraelSponsors and collaborators
Source ClinicalTrials.gov